Quantitative measurement of postural sway in mouse models of human neurodegenerative disease

Neuroscience

Volumn 148, Issue 4, 2007, Pages 825-832

  Hutchinson, D ^a   Ho, V ^b   Dodd, M ^b   Dawson, H N ^a   Zumwalt, A C ^a   Schmitt, D ^a   Colton, C A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of Bath   (United Kingdom)

Author keywords

behavior; center of pressure assay; models; neurodegeneration; postural sway; tremor

Indexed keywords

HARMALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY EQUILIBRIUM; CHROMOSOME 17; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; MEASUREMENT; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL;

AGE FACTORS; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BIOMECHANICS; DISEASE MODELS, ANIMAL; FEMALE; HARMALINE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; MUTATION; NEURODEGENERATIVE DISEASES; NITRIC OXIDE SYNTHASE TYPE II; POSTURE; TREMOR;

EID: 34548686801     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.07.025     Document Type: Article

References (32)

1. Arendash G., Lewis J., Leighty R., McGowan E., Cracchiolo J., Hutton M., and Garcia M. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 1012 (2004) 29-41
2. Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J 81 (2005) 756-762
3. Bove M., Marinelli L., Avanzino L., Marchese R., and Abbruzzese G. Posturographic analysis of balance control in patients with essential tremor. Mov Disord 21 (2006) 192-198
4. Braak H., Ghebremedhim E., Rub U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease related pathology. Cell Tissue Res 318 (2004) 121-134
5. Cenci M.A., Whishaw I.Q., and Schallert T. Animal models of neurological deficits: how relevant is the rat?. Nat Rev 3 (2002) 574-579
6. Colton C., Vitek M., Wink D., Xu Q., Cantillana V., Previti M., VanNostrand W., Weinberg J., and Dawson H. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103 (2006) 12867-12872
7. Davis J., Xu R., Deane G., Romanov M., Previti M., Zeigler K., Zlokovic B., and VanNostrand W. Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor. J Biol Chem 279 (2004) 20296-20306
8. Dawson H, Cantillana V, Vitek M. The tau N279K exon 10 splicing mutation recapitulates FDTP-17 tauopathy in a mouse model. J Neurosci, in press.
9. Fowler S., Birkestrand B., Chen R., Moss S., Vorontsova E., Wang G., and Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 107 (2001) 107-124
10. Fowler S., Zarcone T., Vorontsova E., and Chen R. Motor and associative deficits in D2 dopamine receptor knockout mice. Int J Dev Neurosci 20 (2002) 309-321
11. Hamm R.J. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J Neurotrauma 18 (2001) 1207-1216
12. Haobam R., Sindhu K., Chandra G., and Mohanakumar K. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Behav Brain Res 163 (2005) 159-167
13. Hefter H., Homberg V., Lange H., and Freund H. Impairment of rapid movement in Huntington's disease. Brain 110 (1987) 585-612
14. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., VanSlegtenhorst M., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein nature. Genetics 25 (2000) 402-405
15. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S., and Bates G. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
16. Martin F., Thu L.A., and Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov Disord 20 (2005) 298-305
17. Masui T., Hasegawa Y., Matsuyama Y., Sakano S., Kawasaki M., and Susuki S. Gender differences in platform measures of balance in rural community dwelling elders. Arch Gerontol Geriatr 41 (2005) 201-209
18. Meredith G.E., and Kang U.J. Behavioral models of Parkinson's disease in rodents: A new look at an old problem. Mov Disord 21 (2006) 1595-1606
19. Miao J., Xu F., Davis J., Otte-Holler I., Verbeek M., and Van Nostrand W. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167 (2005) 505-515
20. Miwa H., Nishi K., Fuwa T., and Mizuno Y. Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine. Neuroreport 11 (2000) 2385-2390
21. Nasreddine Z., Loginov M., Clark L., Lamarche J., Miller B., Lamontagne A., Zhukareva V., Lee V., Wilhelmsen K., and Geschwind D. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 45 (1999) 704-715
22. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., SantaCruz K., Guimaraes A., Yue M., Lewis J., Carlson G., Hutton M., and Ashe K. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25 (2005) 10637-10647
23. Rocchi L., Chiari L., and Cappello A. Feature selection of stabilometric parameters based on principal component analysis. Med Biol Eng Comput 42 (2004) 71-79
24. Rocchi L., Chiari L., Cappello A., and Horak F. Identification of distinct characteristics of postural sway in Parkinson's disease: a feature selection procedure based on principal component analysis. Neurosci Lett 39 (2006) 140-145
25. Sango K., McDonald M., Crawley J., Mack M., Tifft C., Skop E., Starr C., Hoffmann A., Sandhoff K., Suzuki K., and Proia R. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 14 (1996) 348-352
26. Schilling G., Becher M., Sharp A., et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8 (1999) 397-407
27. Sieradzan K., and Mann D. The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol 27 (2001) 1-21
28. van der Staay F.J., and Steckler T. The fallacy of behavioral phenotyping without standardisation. Genes Brain Behav 1 (2002) 9-13
29. von Bohlen Und Halbach O. Modeling neurodegenerative diseases in vivo review. Neurodegener Dis 2 (2005) 313-320
30. Wang G., and Fowler S.C. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine. Psychopharmacology 158 (2001) 273-280
31. Xu F., Grande A.M., Robinson J.K., Previti M.L., Vasek M., Davis J., and Van Nostrand W.E. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 146 (2007) 98-107
32. Zumwalt A., Hamrick M., and Schmitt D. A force platform for measuring ground reaction forces in small animal locomotion. J Biomech 39 (2006) 2877-2881